Register
Login:
Share:
Email Facebook Twitter


Fund Manager Chris Bailey talks about an opportunist 2017 for investors


Immupharma Share Price (IMM)



Share Price Information for Immupharma (IMM)


Share Price: 52.75Bid: 52.00Ask: 53.50Change: -1.00 (-1.86%)Faller - Immupharma
Spread: 1.50Spread as %: 2.88%Open: 52.50High: 52.75Low: 52.00Yesterday’s Close: 53.75

Immupharma Plc Ord 10P

Immupharma is listed in the FTSE AIM All-Share
Immupharma is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
52.75

Share Price SpacerBid
52.00

Share Price SpacerAsk
53.50

Share Price SpacerChange
-1.86%-1.00

Share Price SpacerVolume
124,461

Share Price SpacerOpen
52.50

Share Price SpacerHigh
52.75

Share Price SpacerLow
52.00

Share Price SpacerClose
53.75

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 124.64m £65.75m 10,000

52 Week High 55.00 52 Week High Date 17-JAN-2017
52 Week Low 23.00 52 Week Low Date 24-FEB-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
15 74,173 50,288 -11.989 -4.40 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

18-Jan-17
16:55:12
52.2454
36,673
Sell* 
52.00
53.50
19.16k
Trade Type:
Ordinary
Bargain conditions apply

18-Jan-17
16:28:25
53.005
260
Buy* 
52.00
53.50
137.81
Trade Type:
Ordinary

18-Jan-17
16:24:17
52.00
7,826
Sell* 
52.00
54.00
4,070
Trade Type:
Automatic execution




View more Immupharma trades >>

Directors Deals for Immupharma (IMM)
Trade DateActionNotifierPriceCurrencyAmountHolding
30-Apr-15Notification of Holding
Trade Notifier Information for Immupharma
Stephane Robert George Mery held the position of Non-Executive Director at Immupharma at the time of this trade.
 Stephane Robert George Mery
002259
24-Jan-13Sell
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
57GBX62,1690
24-Jan-12Buy
Trade Notifier Information for Immupharma
Ajay Agrawal held the position of Non-Executive Director at Immupharma at the time of this trade.
 Ajay Agrawal
80GBX62,1690
View more Immupharma directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 05:46JdubyaLupus market53.75Strong Buy
.....Wow.....So now, the ridiculous shareprice we all think this could possibly go to...But all, don't want to say for fear of ramping, has now increased even further.
Tue 23:40leasRE: Lupus Market to grow- $3.2B by 202553.75No Opinion
oilbagger, great research. I see IMM got a mention and I bet their results beat all the other competitors Great PR for the company and puts us on the radar. There is also the probability that there are other autoimmune diseases that can benefit from development in the science.
Tue 22:49oilbaggerLupus Market to grow- $3.2B by 202553.75Strong Buy
The lupus market, which covers systemic lupus erythematosus (SLE) and lupus nephritis (LN), is set to almost triple from $1.2 billion in 2015 to $3.2 billion by 2025, representing a compound annual growth rate of 10.6%, according to research and consulting firm GlobalData.
see https://healthcare.globaldata.com/media-center/press-releases/pharmaceuticals/lupus-market-will-reach-32-billion-by-2025-driven-by-new-firstinclass-products-says-globaldata
Tue 20:17LostinfranceRE: hunky53.75No Opinion
I totally agree with hunky, its nice to see the rise but a long way to go as yet,
I first bought 3-4 years ago to presant day, and originally paid high 60,s and down into the 20's and now im making a good profit, but i will not be shouting untill its in the pounds.

A bit of magasine publicity would not go amiss,
Tue 18:42leashunky53.75No Opinion
Agree, always good to keep expectations in perspective. Your entry price here and over at MTFB negates any risk in respect of your original investment. Your timing seems to be perfect in relation to knowing where the bottom is. In any case good luck with your portfolio.
Tue 17:27hunkymonkeyRE: Target...53.75No Opinion
Leas - I'm going to be completely honest, I find it hard to keep a lid on this share, what I said today in all honesty is bare minimum (I don't ever want to come across rampy!) I have a £ figure in mind, I dare not share though, needless to say, it's quite high. But Keep expectations low go for minimums and anything above is a bonus.
I like this bb as you get good informative info, without any bs. When looking at this, you only have to look at the other pharma we are in, there comparisons… Read More

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Immupharma (IMM) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.